Aluminum inhibits erythropoiesis in vitro.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Clinical Investigation

• Publication date

  1988-06-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1172/JCI113502PMID 3384943PMCID PMC442607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Removal of transferrin from fetal bovine serum.

  1987cited by this paper
• Interpretation of serum aluminum values in dialysis patients.

  1986cited by this paper
• Effect of aluminum on hematopoiesis.

  1986cited by this paper
• Aluminium-induced anaemia in haemodialysis patients.

  1985cited by this paper
• Distribution of Aluminium between Plasma and Erythrocytes

  1985cited by this paper
• Distribution of aluminium between plasma and erythrocytes.

  1985cited by this paper
• Serum aluminum cannot be measured accurately.

  1985cited by this paper
• Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?

  1985cited by this paper
• Microcytic anemia secondary to intraperitoneal aluminum in normal and uremic rats.

  1984cited by this paper
• The competitive equilibrium between aluminium and ferric ions for the binding sites of transferrin

  1984cited by this paper
• Quantitative study of aluminum binding to human serum albumin and transferrin by a chelex competitive binding assay.

  1984cited by this paper
• Transferrin: physiologic behavior and clinical implications.

  1984cited by this paper
• Electrothermal atomic absorption spectrometric determination of aluminum in serum with a new technique for protein precipitation.

  1984cited by this paper
• Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.

  1983cited by this paper
• Influence of aluminium hydroxide intake on haemoglobin concentrations and blood transfusion requirements in haemodialysis patients.

  1983cited by this paper
• Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.

  1983cited by this paper
• Plasma aluminum is bound to transferrin.

  1983cited by this paper
• Bone marrow aluminium storage in renal failure.

  1983cited by this paper
• Aluminium interaction with 67Ga uptake by human plasma and transferrin.

  1983cited by this paper
• Hypercalcaemic osteomalacia due to aluminium toxicity.

  1982cited by this paper
• Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate.

  1982cited by this paper
• Characteristics of circulating erythroid colony‐forming cells in normal and polycythaemic man

  1982cited by this paper
• Bone aluminum and histomorphometric features of renal osteodystrophy.

  1982cited by this paper
• Changes in cell surface antigen expression during hemopoietic differentiation.

  1982cited by this paper
• Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

  1981cited by this paper
• Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

  1981cited by this paper
• Haemodialysis related osteomalacia: a staining method to demonstrate aluminium

  1981cited by this paper
• The clinical biochemistry of aluminum.

  1981cited by this paper
• Porphyrias and the kidney.

  1981cited by this paper
• Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication.

  1980cited by this paper
• Dialysis osteomalacia and aluminum intoxication.

  1980cited by this paper
• A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.

  1980cited by this paper
• Changes in serum aluminium, blood zinc, blood lead and erythrocyte δ-aminolaevulinic acid dehydratase activity during haemodialysis

  1979cited by this paper
• Dementia, renal failure, and brain aluminum.

  1979cited by this paper
• Dialysis encephalopathy: recovery after interruption of aluminium intake.

  1978cited by this paper
• Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.

  1978cited by this paper
• Aluminium studies in dialysis encephalopathy.

  1978cited by this paper
• Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase.

  1977cited by this paper
• The Effect of pH upon Human Transferrin: Selective Labelling of the Two Iron‐binding Sites

  1976cited by this paper
• The dialysis encephalopathy syndrome. Possible aluminum intoxication.

  1976cited by this paper
• Iron-donating properties of transferrin.

  1975cited by this paper
• Letter: Aluminium-induced porphyria in rats.

  1973cited by this paper
• ALUMINIUM-INDUCED PORPHYRIA IN RATS

  1973cited by this paper
• SYNDROME OF DYSPRAXIA AND MULTIFOCAL SEIZURES ASSOCIATED WITH CHRONIC HEMODIALYSIS

  1972cited by this paper
• The inhibition of ferroxidase by trivalent and other metal ions.

  1970cited by this paper

• Local and Systemic Hypoxia as Inductors of Increased Aluminum and Iron Brain Accumulation Promoting the Onset of Alzheimer’s Disease

  2023cites this paper
• Mechanism of Mitogenic Action of Aluminum Ion on Bone Cells : Potential Involvement of the Insulin-Like Growth Factor Regulatory System

  2020cites this paper
• Occupational exposure to aluminum and its biomonitoring in perspective

  2012cites this paper
• A intoxicação por alumínio nos doentes em hemodiálise - uma perspetiva histórica

  2012influential citation
• Hyporesponsiveness to erythropoietin: causes and management.

  2009cites this paper
• Heme oxygenase induction

  2008cites this paper
• Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide

  2007cites this paper
• Chapter 1 – Aluminium Induced Disease in Subjects with and without Renal Failure—Does It Help Us Understand the Role of Aluminium in Alzheimer’s Disease?

  2001cites this paper
• Aluminium Toxicity in Erythropoiesis. Mechanisms Related to Cellular Dysfunction in Alzheimer’s Disease

  2001cites this paper
• Biochemical and Hematological Changes in Low-Level Aluminum Intoxication

  2000cites this paper
• Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion.

  2000cites this paper
• Does Abnormal Trace Element Metabolism Contribute to Dialysis Patient Morbidity? Opinion

  1999cites this paper
• Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium.

  1999cites this paper
• Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

  1999cites this paper
• Interference of aluminium on iron metabolism in erythroleukaemia K562 cells.

  1999cites this paper
• Binding and Transport of Nonferrous Metals by Serum Transferrin

  1998cites this paper
• Hematologic Disorders in Renal Failure

  1998cites this paper
• Oral aluminum administration to rats with normal renal function. 1. Impairment of erythropoiesis

  1998cites this paper
• Recombinant Human Erythropoietin Resistance in Iron-Replete Hemodialysis Patients: Role of Aluminum Toxicity

  1998cites this paper
• Erythropoietin and iron.

  1997cites this paper
• Aluminium accumulation in chronic renal failure affects erythropoiesis

  1997cites this paper
• Binding and transport of aluminum by serum proteins

  1996cites this paper
• Aluminum alters iron and manganese uptake and regulation of surface transferrin receptors in primary rat oligodendrocyte cultures.

  1996cites this paper
• Erythropoietin (rHuEPO) 不応性貧血

  1996cites this paper
• Depressed erythroid progenitor cell activity in aluminum-overloaded mice.

  1996cites this paper
• Effect of iron status on the intestinal absorption of aluminum: a reappraisal.

  1996cites this paper
• Effect of aluminum on hematopoiesis after intraperitoneal exposure in rats.

  1996cites this paper
• Treatment of aluminum overload using a cartridge with immobilized desferrioxamine.

  1995cites this paper
• The absence of extracellular calcium potentiates the killing of cultured hepatocytes by aluminum maltolate.

  1995cites this paper
• Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication.

  1995cites this paper
• Evidence-based recommendations for the clinical use of recombinant human erythropoietin.

  1995cites this paper
• 11 – Hematopoietic System

  1995cites this paper
• Biochemical Mechanisms of Aluminum Toxicity

  1995cites this paper
• The inhibitory action of aluminum on mouse bone marrow cell growth: evidence for an erythropoietin- and transferrin-mediated mechanism.

  1994cites this paper
• Aluminiumkontaminierte Infusionslösungen: Ein wenig beachtetes iatrogenes Risiko in der Intensivmedizin

  1994cites this paper
• Heme oxygenase induction. A possible factor in aluminum-associated anemia.

  1994cites this paper
• [Aluminum contaminated infusion solutions: a little appreciated iatrogenic health risk in intensive care medicine].

  1994cites this paper
• Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin.

  1993cites this paper
• Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction.

  1993cites this paper
• Hematological effects of aluminum on living organisms.

  1993cites this paper
• Erythropoietin and the anemia of chronic diseases.

  1993cites this paper
• Aluminum Toxicity in Patients with Chronic Renal Failure

  1993cites this paper
• Cellular, biochemical, and molecular mechanisms of aluminium toxicity.

  1993cites this paper
• Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.

  1993cites this paper
• Determinants of gastrointestinal absorption and distribution of aluminium in health and uraemia.

  1993cites this paper
• Aluminium overload and response to recombinant human erythropoietin in patients under chronic haemodialysis.

  1992cites this paper
• Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture.

  1992cites this paper
• Toxicity of aluminium: a historical review, Part 1.

  1992cites this paper
• Hematological changes after long-term aluminum administration to normal adult rabbits.

  1992cites this paper
• Renal osteodystrophy: pathophysiology.

  1992cites this paper
• Resorption und Toxizität von Aluminium bei Niereninsuffizienz

  1992cites this paper
• 維持透析患者における赤血球内アルミニウム (RBC-AI) 濃度と鉄パラメータについて

  1992cites this paper
• Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.

  1991cites this paper
• Recombinant human erythropoietin. Experimental and clinical applications.

  1991cites this paper
• Clinical and histologic features of iron-related bone disease in dialysis patients.

  1991cites this paper
• Iron uptake in aluminium overload: in vivo and in vitro studies.

  1991cites this paper
• Aluminum effect on the activity of superoxide dismutase and of other antioxygenic enzymes in vitro

  1991cites this paper
• Other clinical syndromes associated with aluminum

  1990cites this paper
• 透析患者の腎性貧血に対するrecombinant human erythropoietin (TYB-5220) の臨床評価

  1990cites this paper
• Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.

  1990cites this paper
• Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells.

  1990cites this paper
• Aluminum inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells.

  1990cites this paper
• Aluminium intoxication in the rat induces partial resistance to the effect of recombinant human erythropoietin.

  1990cites this paper
• The inhibitory factors of hematopoiesis in chronic hemodialysis patients treated with recombinant human erythropoietin.

  1990cites this paper
• Aluminum Toxicity in Humans

  1990cites this paper
• Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum.

  1990cites this paper
• Erythropoietin, aluminium, and anaemia in patients on haemodialysis.

  1990cites this paper
• Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.

  1990cites this paper
• The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.

  1990cites this paper
• Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.

  1989cites this paper
• Die Toxizität des Aluminiums

  1989cites this paper
• [Aluminum toxicity].

  1989cites this paper
• Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis

  1989cites this paper
• Erythropoietin in health and disease

  1989cites this paper